First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the <sup>111</sup>In-ABY-025 Affibody Molecule - Concepedia

Concepedia

Publication | Open Access

First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the <sup>111</sup>In-ABY-025 Affibody Molecule

DOI Full Paper Access

257

Citations

24

References

2014

Year

Jens Sørensen, Dan Sandberg, Mattias Sandström, Anders Wennborg, Joachim Feldwisch, Vladimir Tolmachev, Gunnar Åström, Mark Lubberink, Ulrike Garske‐Román, Jörgen Carlsson,

Journal of Nuclear Medicine

Abstract

(111)In-ABY-025 appears safe for use in humans and is a promising noninvasive tool for discriminating HER2 status in metastatic breast cancer, regardless of ongoing HER2-targeted antibody treatment.

References

	Year	Citations

Page 1